ARID1A substitutions that we identified in gastric tumors, not annotated in human mutation databases, namely p.R2236C, p.Q1415H, and p.P1710L, are of interest since they can lead to deregulation of molecular mechanisms important for cancer progression. This evidence concerns the gene ARID1A and cancer.